Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for Patients with mCRPC By Ogkologos - August 27, 2025 494 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-3 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR Girls Become Best Friends In Hospital, Reunite Years Later For “Survivors”... March 22, 2019 Treatment for Children with Leukemia Also Effective for Adolescents, Young Adults February 25, 2019 Lisocabtagene Maraleucel in Relapsed or Refractory Large B-cell Lymphomas September 7, 2020 Woman Perfectly Breaks Down Grief Using ‘Ball In The Box’ Analogy... March 8, 2019 Load more HOT NEWS EMA Recommends Granting a Marketing Authorisation for Toripalimab Five Questions With…Amber. Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers Resource Round-Up: 2Unstoppable
